More Sites

Stanmore Coal Limited

0.076
CHANGE
-0.001 (-1.3%)
20 minute delayed prices during trading hours
VOLUME
23.3K
DAY'S HIGH
0.076
DAY'S LOW
0.076
Stanmore Coal Limited is an Australian-based company with a portfolio of development and exploration properties. The Company explores and develops projects that host coking, thermal and pulverized coal injection (PCI) coal. The Company has about 2,000 square kilometers of exploration tenements which sit within Queensland's prime Bowen Basin and Surat Basin coal regions. Its projects include Belview, located in Bowen Basin for Metallurgical Coal and PCI Coal; The Ran... continued
COMPARED TO..
advertisement
Stanmore Coal Limited
Stanmore Coal Limited is an Australian-based company with a portfolio of development and exploration properties. The Company explores and develops projects that host coking, thermal and pulverized coal injection (PCI) coal. The Company has about 2,000 square kilometers of exploration tenements which sit within Queensland's prime Bowen Basin and Surat Basin coal regions. Its projects include Belview, located in Bowen Basin for Metallurgical Coal and PCI Coal; The Range, located in Surat Basin for Thermal Coal; Lilyvale, located in Bowen Basin for Metallurgical Coal; Mackenzie, located in Bowen Basin for Metallurgical Coal; Tennyson, located in Bowen Basin for Thermal Coal; Clifford, located in Surat Basin for Thermal Coal; Kerlong, located in Bowen Basin for Metallurgical Coal, and New Cambria, located in Bowen Basin for Metallurgical Coal.

Peer Comparison

Our Peer Comparison tool shows you the current top 5 and bottom 5 performing companies in the ASX.

Latest SMR news

FN Arena Broker Call Headlines - 14 Mar 2013
Credit Suisse rates as Neutral (3) - Credit Suisse was underwhelmed by the strategy update, seeing near-term cost issues associated with the implementation costs, while the medium term benefits seem to be just a continuation of the current trajectory.
8626147
FN Arena Broker Call Headlines - 17 Apr 2012
JP Morgan rates as Neutral (3) - JP Morgan analysts have been seriously disappointed by the released feasibility study of the company's Merlin molyrhenium project.
8452603
FN Arena Broker Call Headlines - 20 Feb 2012
RBS Australia rates as Buy (1) - The broker notes the US Ccongress has forestalled Medicare major physician payment cuts through 2012.
8422458
+ MORE SMR NEWS
Personal Finance: tips for trading shares
Sharemarket basics: A Numbers GameLooking for shares to back? You'll need all the help you can get. Investing in shares can be something of a numbers game, especially when the financial press is peppered with mention of ratios such as "dividend yield" and "earnings per share". Sharemarket basics: How to Sell SharesWhen you didn't buy your shares in the first place, it's difficult to know where to start when you want to offload them. Allison Tait finds out how best to sell, sell, sell! Learners guide: Investing OverseasInvestors looking to diversify their portfolio could explore the option of investing overseas - after all, the Australian sharemarket represents only a small percentage of the world's markets.


Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon.

"Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

FTSE®", FT-SE®", Footsie®", ["FTSE4Good®" and "techMARK"] are trade marks jointly owned by the London Stock Exchange Plc and The Financial Times Limited and are used by FTSE International Limited ("FTSE") under licence. ["All-World®", All- Share®"; and "All-Small®"; are trade marks of FTSE.] "The FTSE [NAME OF FTSE INDEX] is calculated by FTSE. FTSE does not sponsor, endorse or promote this product and is not in any way connected to it and does not accept any liability in relation to its issue, operation and trading."